UBS' equities desk started the new financial year with a bang, netting what was easily the biggest trade of the day on Wednesday.
CSL chief executive Paul Perreault.
The Swiss bank's team handled a $180 million parcel of CSL shares, in what traders reckon was also the biggest institutional block trade of 2020 to date.
The deal involved 629,000 CSL shares at $283 each, and crossed the market via UBS' blocks desk in early afternoon traded,
CSL shares finished the day at $284.40.
The blood products giant's shares are trading up 3.4 per cent year-to-date but have fallen more than 16 per cent since reaching record highs in excess of $340 in February this year.
The purchase off Netherlands company uniQure forms part of CSL's push into the gene therapy space. The company made its first major move into the space in 2017 when it acquired Caliummune .
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Anthony Macdonald co-edits Street Talk, specialising in private equity, investment banking, M&A and equity capital markets. He has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter . Email Anthony at a.macdonald@afr.com
Tim Boyd is a journalist based in Sydney who writes for the Street Talk column. Connect with Tim on Twitter . Email Tim at tim.boyd@afr.com
